Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

DPPE is a ligand for the antiestrogen-binding site (AEBS; Ki = 55.6 nM in rat liver microsomes) and derivative of tamoxifen (Item No. 11629).1 It is selective for the AEBS over the estrogen receptor when used at a concentration of 10 µM. DPPE is cytotoxic to S10 and MCF-7 cells (IC50s = 7.5 and 12 µM) and inhibits antigen-induced histamine release in isolated rat mast cells (IC50 = 65-85 µM).2,3 It decreases uterine size in immature oophorectomized rats in a dose-dependent manner.4 DPPE (4 mg/kg) protects bone marrow progenitor cells from cytotoxicity induced by doxorubicin (Item No. 15007) in mice.2
WARNING This product is not for human or veterinary use.
1. Synthesis, binding and structure-
2. Increased therapeutic index of antineoplastic drugs in combination with intracellular histamine antagonists. J. Natl. Cancer Inst. 83(18), 1329-1336 (1991).
3. Influence of DPPE on histamine release from isolated rat mast cells. Agents Actions 41(1-2), 1-4 (1994).
4. Study of the in-